Mohammad Moniruzzaman

Mohammad Moniruzzaman

Auto-generated profile, based on publicly available information

Mohammad Moniruzzaman

Department of Chemistry and Biochemistry, University of Oklahoma, Norman, USA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 January 2023 in ACS Infectious Diseases
Verified
Journal Article
Closed access
MSMarianna Stampolaki
Marianna Stampolaki
SMSatish Malwal
Satish Malwal
Nadine AlvarezNadine Alvarez
Nadine Alvarez
ZGZijun Gao
Zijun Gao
MMMohammad Moniruzzaman
Mohammad Moniruzzaman
AKAntonios Kolocouris
Antonios Kolocouris

18 July 2023 in Nature Communications
Verified
Journal Article
Open access
PDF file
BLBenjamin Russell Lewis
Benjamin Russell Lewis
MUMuhammad R. Uddin
Muhammad R. Uddin
MMMohammad Moniruzzaman
Mohammad Moniruzzaman
KKKatie M. Kuo
Katie M. Kuo
AHAnna J. Higgins
Anna J. Higgins
EREamonn Reading
Eamonn Reading
Membrane efflux pumps play a major role in bacterial multidrug resistance. The tripartite multidrug efflux pump system fromEscherichia coli, AcrAB-TolC, is a target for inhibition to lessen resistance development and restore antibiotic efficacy, with homologs in other ESKAPE pathogens. Here, we rationalize a mechanism of inhibition against the periplasmic adaptor protein, AcrA, using a combination of hydrogen/deuterium exchange mass spectrometry, cellular efflux assays, and molecular dynamics simulations. We define the structural dynamics of AcrA and find that an inhibitor can inflict long-range stabilisation across all four of its domains, whereas an interacting efflux substrate has minimal effect. Our results support a model where an inhibitor forms a molecular wedge within a cleft between the lipoyl and αβ barrel domains of AcrA, diminishing its conformational transmission of drug-evoked signals from AcrB to TolC. This work provides molecular insights into multidrug adaptor protein function which could be valuable for developing antimicrobial therapeutics.

9 December 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
BLBenjamin Russell Lewis
Benjamin Russell Lewis
MUMuhammad R. Uddin
Muhammad R. Uddin
MMMohammad Moniruzzaman
Mohammad Moniruzzaman
KKKatie M. Kuo
Katie M. Kuo
AHAnna J. Higgins
Anna J. Higgins
EREamonn Reading
Eamonn Reading
Membrane efflux pumps play a major role in bacterial multidrug resistance. The tripartite multidrug efflux pump system from Escherichia coli , AcrAB-TolC, is a target for inhibition to lessen resistance development and restore antibiotic efficacy, with homologs in other ESKAPE pathogens. Here, we rationalize a mechanism of inhibition against the periplasmic adaptor protein, AcrA, using a combination of hydrogen/deuterium exchange mass spectrometry, cellular efflux assays, and molecular dynamics simulations. We define the structural dynamics of AcrA and find that an inhibitor can inflict long-range stabilisation across all four of its domains, whereas an interacting efflux substrate has minimal effect. Our results support a model where an inhibitor forms a molecular wedge within a cleft between the lipoyl and αβ domains of AcrA, diminishing its conformational transmission of drug-evoked signals from AcrB to TolC. This work provides molecular insights into multidrug adaptor protein function which could be valuable for developing antimicrobial therapeutics.